Prognostic Biomarkers of Pancreatic Cancer Based on Proteomics Techniques

Qingdao University

Status: Unknown

Conditions: Patients

Study type: Observational

Funder types: Other

Identifiers

NCT05088161

JJDB-SR-2021-02

Details and patient eligibility

About

In this study, we will use high-throughput proteomics techniques to search for biomarkers of post-operative prognosis of pancreatic cancer in samples of patients who have been diagnosed with pancreatic cancer through bioinformatics analysis.

Full description

This study plan from the affiliated hospital of Qingdao university collected 20 cases of patients with pancreatic cancer pathological tissue samples and clinical data, including clinical diagnostic information, laboratory tests, imaging examination results and other information data), through high-throughput proteomic technology in pancreatic cancer pathological finding biomarkers, the bioinformatics analysis to explore the prognosis biomarkers.

Enrollment: 20 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients of Chinese nationality, age and gender are not limited.
• Pathologically confirmed pancreatic cancer patients.
• Pathological specimens were archived tumor tissue samples after a diagnosis of pancreatic cancer.
• Clinical diagnostic information was complete three months before sampling.

Exclusion criteria

• Patients with a second primary tumor.